My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


China's $500B Memory Giant Isn't Chasing Nvid...
Coca-Cola Q2 Preview: Stock Near All-Time Hig...
Toyota’s New Partnership Deepens Its Fuel-Cel...
Intel’s Earnings Could Quadruple in 4 Years,...
SpaceX’s AI Could Be Worth Nothing If Stock H...
Amazon Stock Edges Higher Ahead of Earnings:...
Nvidia's Next Product Could Be Credit, Not Ch...
Ford Wants to Turn Car Customization Into the...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    DIAMEDICA THERAPEUTICS INC (NASDAQ: DMAC)

    Overview
    current price
    $6.74
    $6.74
    change
    0.01 | 0.07%
    0.01 | 0.07%
    Yesterday's Close
    6.74
    open
    6.79
    volume
    0.09 M
    30d. avg volume.
    0.24 M
    1 day
    6.65 - 7.13
    52 weeks
    4.01 - 10.42
    p/e
    0.00
    beta
    0.9751
    market cap
    0.36 B
    dividend yield
    0.00%
    Industry
    -
    DMAC by TradingView
    News and Commentary
    4 IPOs on the Schedule, But More Could Follow There are a total of four IPO's on the schedule this week. Most of them are focused in the biotech sector and one is a China-based fashion website. There are a few names becoming...
    Last Call for IPOs in 2018 Following the shortened Thanksgiving week here in the states, there's potentially only one IPO that could launch. As the year nears its end, the clock is ticking for any names th...
    StockTwits
    StockTwits
    Most Shared
    AI Making Life More Expensive for You? Federal Reserve Says 'Upward Pressure' Likely to Sustain for Now
    AMD Rises After Microsoft's Helios Win: Is Nvidia Finally Facing Real Competition?
    Comcast Stock Soars On Split News, Does Disney Need To Make A Similar Move?
    Most Popular
    Bloom Energy Hit By Explosive Short Report Questioning China-Free Supply Claims
    Nvidia, Meta and 23 Others Put Their Names on Open-Weight AI Letter — Google, Amazon and the Closed Labs Keep Theirs Off
    AMD Stock Drops 5%: Why Global Supply Chain Fears and Tech Profit-Taking Are Hurting Chip Giants
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Microsoft
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?